Related Experiment Video
Updated: May 26, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Prospects for primary stroke prevention in children with sickle cell anaemia
Lori C Jordan1, James F Casella, Michael R DeBaun
1Department of Neurology, Division of Pediatric Neurology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Insights
This review examines current stroke prevention methods for children with sickle cell anaemia (SCA), focusing on transcranial Doppler (TCD) screening and blood transfusions. It also explores alternative strategies like immunizations and novel therapies to prevent neurological injury.
Area of Science:
- Pediatric Hematology
- Neurology
- Public Health
Background:
- Sickle cell anaemia (SCA) poses a significant risk for ischaemic strokes in children.
- Current primary stroke prevention relies on transcranial Doppler (TCD) ultrasound screening.
- Blood transfusion therapy is the standard intervention based on TCD findings from clinical trials.
Purpose of the Study:
- To review the strengths and limitations of the current standard of care for primary stroke prevention in pediatric SCA.
- To discuss theoretical alternative strategies for preventing neurological injury in SCA patients.
- To highlight potential new approaches for stroke risk reduction in this population.
Main Methods:
- Literature review of existing studies on stroke prevention in SCA.
- Analysis of the current standard of care: TCD screening and blood transfusions.
- Exploration of theoretical frameworks for alternative preventative strategies.
Main Results:
- The current TCD screening and transfusion protocol has demonstrated efficacy but also presents limitations.
- Alternative strategies, including immunizations and blood pressure management, show promise, especially in resource-limited settings.
- Novel therapies like hydroxycarbamide and hematopoietic stem cell transplant offer potential for improved long-term prevention.
Conclusions:
- The current standard of care for stroke prevention in pediatric SCA has limitations that warrant further investigation.
- Alternative and adjunctive strategies are crucial for comprehensive neurological protection in children with SCA.
- Future research should focus on optimizing existing methods and validating novel approaches to reduce stroke incidence.
Abstract:
This review will focus on the strengths and limitations associated with the current standard of care for primary prevention of ischaemic strokes in children with sickle cell anaemia (SCA) - transcranial Doppler ultrasound (TCD) screening followed by regular blood transfusion therapy when TCD measurement is above a threshold defined by a randomized clinical trial (RCT). The theoretical basis for potential alternative strategies for primary prevention of neurological injury in SCA is also discussed. These strategies will include, but will not be limited to: immunizations to prevent bacterial infections, particularly in low income countries; management of elevated blood pressure; and targeted strategies to increase baseline haemoglobin levels with therapies such as hyroxycarbamide or potentially definitive haematopoietic stem cell transplant.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology